XtalPi Achieves Milestone with siRNA Candidate for IgA Nephropathy in Just Nine Months #USA #Cambridge #IgA_nephropathy #XtalPi_Holdings #siRNA_therapeutics

XtalPi Achieves Milestone with siRNA Candidate for IgA Nephropathy in Just Nine Months #USA #Cambridge #IgA_nephropathy #XtalPi_Holdings #siRNA_therapeutics
Alebund Pharmaceuticals Secures FDA Approval for AP308 to Treat IgA Nephropathy #China #Shanghai #FDA #IgA_nephropathy #Alebund